Novartis AG Full Year Results News Conference As Company Mulls IPO For Alcon Unit

Vasant Narasimhan, chief medical officer of Novartis AG, looks on during a news conference to announce the company's results in Basel, Switzerland, on Wednesday, Jan. 25, 2017. Novartis proposed buying back $5 billion of shares and said it's considering separating its embattled eye-care division after projecting that sales this year at Europe's second-biggest drugmaker will likely be largely unchanged from 2016. Photographer: Michele Limina/Bloomberg via Getty Images
Vasant Narasimhan, chief medical officer of Novartis AG, looks on during a news conference to announce the company's results in Basel, Switzerland, on Wednesday, Jan. 25, 2017. Novartis proposed buying back $5 billion of shares and said it's considering separating its embattled eye-care division after projecting that sales this year at Europe's second-biggest drugmaker will likely be largely unchanged from 2016. Photographer: Michele Limina/Bloomberg via Getty Images
Novartis AG Full Year Results News Conference As Company Mulls IPO For Alcon Unit
PURCHASE A LICENSE
How can I use this image?
€475.00
EUR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
632647636
Collection:
Bloomberg
Date created:
January 25, 2017
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
SWITZERLAND NOVARTIS
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 6 MB